American Journal of Psychiatry

SF Signer and YD Lapierre

doi: N/Apmid: N/A

CD Karkanias, GA Block, S Reines, and J Bradwejn

doi: N/Apmid: N/A

CE Schwartz

doi: N/Apmid: N/A

Miller, IW; Norman, WH; Keitner, GI

doi: N/Apmid: 2782470

The authors report 6- and 12-month follow-up data for 45 depressed inpatients who were randomly assigned to either standard treatment (hospital milieu therapy, pharmacotherapy, clinical management sessions), cognitive therapy plus standard treatment, or social skills training plus standard treatment. All treatments began in the hospital and continued for 4 months after discharge on an outpatient basis. Significantly higher proportions of the patients who received additional cognitive-behavioral treatment (cognitive therapy or social skills) had responded by the end of the formal treatment period and did not relapse for the remainder of the

Segal, JH

doi: N/Apmid: 2675641

Erotomania, the persistent delusion of being loved from afar by another person, has defied easy categorization for years. Kraepelin and de Clerambault both discussed the syndrome in detail, but it has recently appeared officially for the first time, in DSM-III-R, as a subtype of delusional (paranoid) disorder, in a return to the original Kraepelinian formulation. The author reviews the history, theories of etiology, course, and treatment of erotomania. He concludes that the DSM-III-R classification is correct and that neuroleptics and enforced separation, although only

Gerald H. Flamm

doi: N/Apmid: N/A

R Balon, VK Yeragani, and R Pohl

doi: N/Apmid: N/A

Baraban, JM; Worley, PF; Snyder, SH

doi: N/Apmid: 2571304

Most models of psychotropic drug action have emphasized effects on the release or uptake of neurotransmitters as well as interactions with receptors. Stimulation of neurotransmitter receptors triggers a complex array of electrical and biochemical actions. Recent experimental advances have greatly clarified the second messenger systems underlying neurotransmitter actions, suggesting novel sites of action for psychotropic agents. The authors emphasize the phosphoinositide system and the

doi: N/Apmid: N/A

Thompson, JW; Pincus, H

doi: N/Apmid: 2782478

The authors describe a crosswalk, or translation, from DSM-III-R to ICD- 9-CM. They present differences in the purposes and formatting of these two documents and discuss different levels of compatibility between the two. They demonstrate several problems at the code, rubric, and case levels of compatibility. Ninety-seven percent of DSM-III-R codes are compatible with ICD-9-CM at the case level. The problems in most cases are minor, and in the authors' opinion are not problems in actual clinical or medical records use. The development of DSM-IV and ICD-10 should include attention to translation issues early in the process from the perspectives of clinical